Relay Therapeutics, Inc.
Total Trades
174
Buys
0
Sells
142
Largest Trade
N/A
Insiders
7
Institutional Funds
170
Inst. Value
$1M+
Activist Filings
23
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Bergstrom Donald A | President, R&D | SELL | $100K–$500K | 22K | $7.72 | Jan 29, 2026 |
| Rahmer Peter | See remarks | GRANT | $1K–$15K | 994 | $2.99 | Jan 29, 2026 |
| Rahmer Peter | See remarks | SELL | $100K–$500K | 13K | $7.71 | Jan 29, 2026 |
| Catinazzo Thomas | CFO | SELL | $100K–$500K | 16K | $7.71 | Jan 29, 2026 |
| Patel Sanjiv | President and CEO | SELL | $100K–$500K | 43K | $7.82 | Jan 7, 2026 |
| Patel Sanjiv | President and CEO | GRANT | $1K–$15K | 994 | $2.99 | Jan 7, 2026 |
| Patel Sanjiv | President and CEO | SELL | $100K–$500K | 62K | $7.00 | Nov 4, 2025 |
| Rahmer Peter | See remarks | SELL | $100K–$500K | 41K | $7.40 | Oct 30, 2025 |
| Catinazzo Thomas | CFO | SELL | $100K–$500K | 22K | $7.29 | Oct 30, 2025 |
| Bergstrom Donald A | President, R&D | SELL | $100K–$500K | 31K | $7.29 | Oct 30, 2025 |
| Rahmer Peter | See remarks | SELL | $50K–$100K | 17K | $3.68 | Jul 30, 2025 |
| Catinazzo Thomas | CFO | SELL | $50K–$100K | 20K | $3.69 | Jul 30, 2025 |
| Bergstrom Donald A | President, R&D | SELL | $100K–$500K | 31K | $3.69 | Jul 30, 2025 |
| Adams Brian | Chief Legal Officer | SELL | $50K–$100K | 20K | $3.68 | Jul 30, 2025 |
| Patel Sanjiv | President and CEO | SELL | $100K–$500K | 61K | $3.57 | Jul 10, 2025 |
| Rahmer Peter | See remarks | SELL | $15K–$50K | 12K | $3.02 | May 1, 2025 |
| Catinazzo Thomas | CFO | SELL | $50K–$100K | 19K | $3.07 | May 1, 2025 |
| Bergstrom Donald A | President, R&D | SELL | $50K–$100K | 32K | $3.02 | May 1, 2025 |
| Adams Brian | Chief Legal Officer | SELL | $15K–$50K | 15K | $3.02 | May 1, 2025 |
| Patel Sanjiv | President and CEO | SELL | $100K–$500K | 61K | $2.97 | Apr 24, 2025 |
| Bergstrom Donald A | President, R&D | SELL | $1K–$15K | 986 | $2.84 | Mar 31, 2025 |
| Rahmer Peter | See remarks | SELL | <$1K | 247 | $2.84 | Mar 31, 2025 |
| Catinazzo Thomas | CFO | SELL | $1K–$15K | 5K | $2.84 | Mar 31, 2025 |
| Adams Brian | Chief Legal Officer | SELL | <$1K | 298 | $2.84 | Mar 31, 2025 |
| Rahmer Peter | See remarks | SELL | $100K–$500K | 45K | $4.50 | Jan 31, 2025 |
| Rahmer Peter | See remarks | GRANT | N/A | 139K | — | Jan 31, 2025 |
| Catinazzo Thomas | CFO | GRANT | N/A | 139K | — | Jan 31, 2025 |
| Catinazzo Thomas | CFO | SELL | $100K–$500K | 59K | $4.55 | Jan 31, 2025 |
| Bergstrom Donald A | President, R&D | SELL | $100K–$500K | 80K | $4.50 | Jan 31, 2025 |
| Bergstrom Donald A | President, R&D | GRANT | N/A | 176K | — | Jan 31, 2025 |
| Adams Brian | Chief Legal Officer | SELL | $100K–$500K | 54K | $4.55 | Jan 31, 2025 |
| Adams Brian | Chief Legal Officer | GRANT | N/A | 139K | — | Jan 31, 2025 |
| Patel Sanjiv | President and CEO | SELL | $1M+ | 375K | $4.70 | Jan 24, 2025 |
| Rahmer Peter | See remarks | SELL | $100K–$500K | 81K | $4.27 | Jan 7, 2025 |
| Adams Brian | Chief Legal Officer | SELL | $1K–$15K | 299 | $4.38 | Dec 31, 2024 |
| Bergstrom Donald A | President, R&D | SELL | $1K–$15K | 657 | $4.38 | Dec 31, 2024 |
| Catinazzo Thomas | CFO | SELL | $15K–$50K | 5K | $4.42 | Dec 31, 2024 |
| Rahmer Peter | See remarks | SELL | $1K–$15K | 400 | $4.38 | Dec 31, 2024 |
| Rahmer Peter | See remarks | SELL | $1K–$15K | 2K | $6.06 | Oct 30, 2024 |
| Catinazzo Thomas | CFO | SELL | $50K–$100K | 9K | $6.03 | Oct 30, 2024 |
| Bergstrom Donald A | President, R&D | SELL | $15K–$50K | 3K | $6.06 | Oct 30, 2024 |
| Adams Brian | Chief Legal Officer | SELL | $1K–$15K | 2K | $6.06 | Oct 30, 2024 |
| Rahmer Peter | See remarks | SELL | $1K–$15K | 245 | $7.51 | Oct 1, 2024 |
| Catinazzo Thomas | CFO | SELL | $15K–$50K | 6K | $7.46 | Oct 1, 2024 |
| Bergstrom Donald A | President, R&D | SELL | $1K–$15K | 648 | $7.51 | Oct 1, 2024 |
| Adams Brian | Chief Legal Officer | SELL | $1K–$15K | 295 | $7.51 | Oct 1, 2024 |
| Catinazzo Thomas | CFO | SELL | $50K–$100K | 11K | $8.56 | Jul 31, 2024 |
| Rahmer Peter | See remarks | SELL | $100K–$500K | 42K | $8.34 | Jul 31, 2024 |
| Bergstrom Donald A | President, R&D | SELL | $15K–$50K | 3K | $8.85 | Jul 31, 2024 |
| Adams Brian | Chief Legal Officer | SELL | $1K–$15K | 2K | $8.85 | Jul 31, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 170 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 27.9M | $1M+ | SH |
| Point72 Asset Management, L.P. | 13.9M | $1M+ | SH |
| STATE STREET CORP | 6.4M | $1M+ | SH |
| Nextech Invest, Ltd. | 4.7M | $1M+ | SH |
| Spruce Street Capital LP | 3.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 2.3M | $1M+ | SH |
| MPM BioImpact LLC | 2.2M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 2.1M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 1.9M | $1M+ | SH |
| Alphabet Inc. | 1.6M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1M | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 912K | $1M+ | SH |
| Kalehua Capital Management LLC | 901K | $1M+ | SH |
| VANGUARD GROUP INC | 861K | $1M+ | SH |
| NORGES BANK | 837K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 648K | $1M+ | SH |
| Allianz Asset Management GmbH | 560K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 541K | $1M+ | SH |
| Rhenman & Partners Asset Management AB | 460K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
7.5%
13.0M shares
SC 13G/A · Feb 17, 2026
7.5%
13.0M shares
SC 13G/A · Nov 14, 2025
9.9%
17.0M shares
SC 13G/A · Aug 14, 2025
7.8%
13.3M shares
Point72 Asset Management, L.P.
SC 13G/A · Aug 14, 2025
7.8%
13.4M shares
SC 13G/A · Jul 29, 2025
5.5%
9.4M shares
SC 13G · May 15, 2025
5.8%
10.0M shares
SC 13G/A · Apr 30, 2025
7.1%
12.1M shares
SC 13G/A · Apr 17, 2025
6.1%
10.3M shares
Point72 Asset Management, L.P.
SC 13G · Mar 20, 2025
5.7%
9.7M shares
SC 13G/A · Feb 5, 2025
8.8%
14.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
3.3%
5.3M shares
SC 13G/A · Feb 14, 2024
6.0%
7.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2024
7.0%
8.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.6%
10.7M shares
SC 13G/A · Jan 26, 2024
7.8%
9.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
4.0%
0 shares
SC 13G · Oct 2, 2023
5.2%
6.3M shares
SC 13G/A · Jul 10, 2023
2.4%
3.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 3, 2023
5.2%
0 shares
SC 13G/A · Jan 31, 2023
6.6%
8.0M shares
SC 13G/A · Oct 11, 2022
9.9%
12.0M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares